A recent study found that structured cessation programs improve quit rates among lung cancer screening participants. How can physicians leverage this?

A recent editorial explores the effectiveness of complex risk models for lung cancer screening, suggesting that simpler ...

Native Americans face the longest travel times, even after accounting for distances in rural areas, according to results of a ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Heather Wakelee, MD, Stanford University, discusses the pros and cons of different durations of immunotherapy in non-small cell lung cancer (NSCLC) and the future outlook for patient-specific care.

So, the American Lung Association has partnered with the Ad Council to launch "Saved by the Scan" to urge all eligible people ...

Scientists have created a new low-cost device to detect lung cancer biomarkers – paving the way for the development of ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.